| 今开：0.0 | 昨收：12.005 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.654349025E9 |
$Synta Pharmaceuticals(SNTA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-07 AccNo: 0001104659-18-049982 Size: 3 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers Filed: 2018-06-05 AccNo: 0001047469-18-004269 Size: 597 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-04-27 AccNo: 0001104659-18-027846 Size: 128 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-13 AccNo: 0001047469-18-001557 Size: 5 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2017-12-21 AccNo: 0001104659-17-074616 Size: 287 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Synta Pharmaceuticals(SNTA)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-12-18 AccNo: 0001047469-17-007712 Size: 1 MB 网页链接